Extrathyroidal extension in well-differentiated thyroid cancer: Macroscopic vs microscopic as a predictor of outcome

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 7, 2007, Pages 644-649

  Hu, Amanda ^a   Clark, Jonathan ^b   Payne, Richard J ^c   Eski, Spiro ^c   Walfish, Paul G ^c   Freeman, Jeremy L ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TERTIARY HEALTH CARE; THYROID CANCER;

BLOOD VESSELS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MALE; MICROSCOPY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECK DISSECTION; NECK MUSCLES; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PERIPHERAL NERVES; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TRACHEA;

EID: 34447515491     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.7.644     Document Type: Article

References (32)

1. Ortiz S, Rodriguez JM, Soria T, et al. Extrathyroid spread in papillary carcinoma of the thyroid: clinicopathological and prognostic study. Otolaryngol Head Neck Surg. 2001;124(3):261-265.
2. Andersen PE, Kinsella J, Loree TR, Shaha AR, Shah JP. Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg. 1995;170(5):467-470.
3. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55(4):805-828.
4. Cody HS III, Shah JP. Locally invasive, well-differentiated thyroid cancer: 22 years' experience at Memorial Sloan-Kettering Cancer Center. Am J Surg. 1981;142(4):480-483.
5. Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy [published correction appears in Semin Oncol. 1988;15(3):x]. Semin Oncol. 1987;14(3):315-332.
6. McCaffrey TV, Bergstralh EJ, Hay ID. Locally invasive papillary thyroid carcinoma 1940-1990. Head Neck. 1994;16(2):165-172.
7. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc. 1986;61(12):978-996.
8. Mizukami Y, Nuguchi M, Michigishi T, et al. Papillary thyroid carcinoma in Kanazawa, Japan: prognostic significance of histological subtypes. Histopathology. 1992;20(3):243-250.
9. Jukkola A, Bloigu R, Ebeling T, Salmela P, Blanco G. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer. 2004;11(3):571-579.
10. Palme CE, Waseem Z, Raza SN, et al. Management and outcome of recurrent well-differentiated thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(7):819-824.
11. Cushing SL, Palme CE, Audet N, Eski S, Walfish PG, Freeman JL. Prognostic factors in well-differentiated thyroid carcinoma. Laryngoscope. 2004;114(12):2110-2115.
12. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma: a study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer. 1979;15(8):1033-1041.
13. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Handbook. 6th ed. Philadelphia, PA: Springer Publishing Co Inc; 2002.
14. DeGroot LJ, Kaplan EL, McCormick M, Strauss FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71(2):414-424.
15. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114(6):1050-1058.
16. Cady B, Rossi R. An expanded view of risk-group definition in well differentiated thyroid carcinoma. Surgery. 1988;104(6):947-953.
17. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery. 1987;102(6):1088-1095.
18. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg. 1992;164(6):658-661.
19. Herrera MF, Lopez-Graniel CM, Saldana J, et al. Papillary thyroid carcinoma in Mexican patients: clinical aspects and prognostic factors. World J Surg. 1996;20(1):94-100.
20. Kowalski LP, Filho JG. Results of the treatment of locally invasive thyroid carcinoma. Head Neck. 2002;24(4):340-344.
21. McCaffrey JC. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology. Laryngoscope. 2006;116(1):1-11.
22. Czaja JM, McCaffrey TV. The surgical management of laryngotracheal invasion by well-differentiated papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 1997;123(5):484-490.
23. Gemsenjäger E, Heitz PU, Seifert B, Martina B, Schweizer I. Differentiated thyroid carcinoma: follow-up of 264 patients from one institution for up to 25 years. Swiss Med Wkly. 2001;131(11-12):157-163.
24. Mazzarotto R, Cesaro MG, Lora O, Rubello D, Casara D, Sotti G. The role of external beam radiotherapy in the management of differentiated thyroid cancer. Biomed Pharmacother. 2000;54(6):345-349.
25. Brierley JD, Tsang RW. External-beam radiation therapy in the treatment of differentiated thyroid cancer. Semin Surg Oncol. 1999;16(1):42-49.
26. Simpson WJ. Radioiodine and radiotherapy in the management of thyroid cancers. Otolaryngol Clin North Am. 1990;23(3):509-521.
27. Brierley JD, Tsang RW. External radiation therapy in the treatment of thyroid malignancy. Endocrinol Metab Clin North Am. 1996;25(1):141-157.
28. Wilson PC, Millar BM, Brierley JD. The management of advanced thyroid cancer. Clin Oncol (R Coll Radiol). 2004;16(8):561-568.
29. Schuck A, Biermann M, Pixberg MK, et al. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma: first results of the Multicenter Study Differentiated Thyroid Carcinoma (MSDS). Strahlenther Onkol. 2003;179(12):832-839.
30. Phlips P, Hanzen C, Andry G, et al. Postoperative irradiation for thyroid cancer. Eur J Surg Oncol. 1993;19(5):399-404.
31. Brierley J, Tsang R, Panzarella T, Bana N. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf ). 2005;63(4):418-427.
32. Farahati J, Reiners C, Stuschke M, et al. Differentiated thyroid cancer: impact of adjuvant external radiotherapy inpatients with perithyroidal tumor infiltration (stage pT4). Cancer. 1996;77(1):172-180.